UB Paderborn / Katalog / Suche / in CDI

Hepatitis Rebound after Infection with Yellow Fever Virus

Emerging infectious diseases, 2019-06, Vol.25 (6), p.1248-1249

2019

Link zum Volltext

Verfügbarkeit prüfen

Molecular characterization of the 17D-204 yellow fever vaccine

Vaccine, 2015-10, Vol.33 (41), p.5432-5436

2015

Link zum Volltext

Verfügbarkeit prüfen

A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults

AIDS (London), 2022-02, Vol.36 (2), p.319-321

2022

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of a Monovalent 2009 Influenza A/H1N1v Vaccine Adjuvanted With AS03A or Unadjuvanted in HIV-Infected Adults: A Randomized, Controlled Trial

The Journal of infectious diseases, 2011-07, Vol.204 (1), p.124-134

2011

Link zum Volltext

Verfügbarkeit prüfen

Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype

PloS one, 2017-05, Vol.12 (5), p.e0177882-e0177882

2017

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2011-04, Vol.305 (14), p.1432

2011

Link zum Volltext

Verfügbarkeit prüfen

Tickborne relapsing fever caused by Borrelia persica, Uzbekistan and Tajikistan

Emerging infectious diseases, 2011-07, Vol.17 (7), p.1325-1327

2011

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis Rebound after Infection with Yellow Fever Virus

Emerging infectious diseases, 2019-06, Vol.25 (6), p.1248

2019

Link zum Volltext

Verfügbarkeit prüfen

Loss of anti-hepatitis C virus antibodies following therapeutic sustained virological response in a HIV co-infected patient

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014-06, Vol.20 (6), p.384-386

2014

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and Safety of Yellow Fever Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients After Withdrawal of Immunosuppressive Therapy

The Journal of infectious diseases, 2018-01, Vol.217 (3), p.494-497

2018

Link zum Volltext

Verfügbarkeit prüfen

Lack of a Clinically Significant Pharmacokinetic Interaction between Etravirine and Raltegravir Using an Original Approach Based on Drug Metabolism, Protein Binding, and Penetration in Seminal Fluid: A Pharmacokinetic Substudy of the ANRS‐163 ETRAL Study

Pharmacotherapy, 2019-04, Vol.39 (4), p.514-520

2019

Link zum Volltext

Verfügbarkeit prüfen

The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial

Medicine (Baltimore), 2016-02, Vol.95 (6), p.e2673-e2673

2016

Link zum Volltext

Verfügbarkeit prüfen

Intensification of Antiretroviral Therapy through Addition of Enfuvirtide in Naive HIV-1-Infected Patients with Severe Immunosuppression Does Not Improve Immunological Response: Results of a Randomized Multicenter Trial (ANRS 130 Apollo)

Antimicrobial Agents and Chemotherapy, 2013-02, Vol.57 (2), p.758-765

2013

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients

AIDS (London), 2018-10, Vol.32 (16), p.2291-2299

2018

Link zum Volltext

Verfügbarkeit prüfen

Quality of Travel Health Advice in a French Travel Medicine and Vaccine Center: A Prospective Observational Study

Journal of travel medicine, 2012-03, Vol.19 (2), p.76-83

2012

Link zum Volltext

Verfügbarkeit prüfen

Rheumatic manifestations caused by tropical viruses

Joint, bone, spine : revue du rhumatisme, 2007-10, Vol.74 (5), p.410-413

2007

Link zum Volltext

Verfügbarkeit prüfen

Spontaneous Hepatic Decompensation in Patients Coinfected with HIV and Hepatitis C Virus during Interferon-Ribavirin Combination Treatment

Clinical infectious diseases, 2005-12, Vol.41 (12), p.1806-1809

2005

Link zum Volltext

Verfügbarkeit prüfen

Manifestations rhumatologiques des viroses exotiques

Revue du rhumatisme (Ed. française : 1993), 2007-10, Vol.74 (9), p.804-808

2007

Link zum Volltext

Verfügbarkeit prüfen

Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities

PloS one, 2015-12, Vol.10 (12), p.e0144317-e0144317

2015

Link zum Volltext

Verfügbarkeit prüfen

Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-study

Vaccine, 2015-09, Vol.33 (38), p.4938-4944

2015

Link zum Volltext

Verfügbarkeit prüfen

6. Les terrains particuliers

Colin de Verdière, Nathalie

2012

Link zum Volltext

Verfügbarkeit prüfen

Personal protection against biting insects and ticks

Parasite (Paris), 2011-02, Vol.18 (1), p.93-111

2011

Link zum Volltext

Verfügbarkeit prüfen

Immunological success is predicted by enfuvirtide but not interleukin-2 therapy in immunodepressed patients

AIDS (London), 2009-07, Vol.23 (11), p.1383-1388

2009

Link zum Volltext

Verfügbarkeit prüfen

Pandemic Influenza A (H1N1) Infection among HIV-Infected Adults in France

Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002), 2011-08, Vol.10 (4), p.229-231

2011

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Hepatitis Rebound after Infection with Yellow Fever Virus

Molecular characterization of the 17D-204 yellow fever vaccine

A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults

Safety and Immunogenicity of a Monovalent 2009 Influenza A/H1N1v Vaccine Adjuvanted With AS03A or Unadjuvanted in HIV-Infected Adults: A Randomized, Controlled Trial

Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype

Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial

Tickborne relapsing fever caused by Borrelia persica, Uzbekistan and Tajikistan

Hepatitis Rebound after Infection with Yellow Fever Virus

Loss of anti-hepatitis C virus antibodies following therapeutic sustained virological response in a HIV co-infected patient

Immunogenicity and Safety of Yellow Fever Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients After Withdrawal of Immunosuppressive Therapy

Lack of a Clinically Significant Pharmacokinetic Interaction between Etravirine and Raltegravir Using an Original Approach Based on Drug Metabolism, Protein Binding, and Penetration in Seminal Fluid: A Pharmacokinetic Substudy of the ANRS‐163 ETRAL Study

The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial

Intensification of Antiretroviral Therapy through Addition of Enfuvirtide in Naive HIV-1-Infected Patients with Severe Immunosuppression Does Not Improve Immunological Response: Results of a Randomized Multicenter Trial (ANRS 130 Apollo)

Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients

Quality of Travel Health Advice in a French Travel Medicine and Vaccine Center: A Prospective Observational Study

Rheumatic manifestations caused by tropical viruses

Spontaneous Hepatic Decompensation in Patients Coinfected with HIV and Hepatitis C Virus during Interferon-Ribavirin Combination Treatment

Manifestations rhumatologiques des viroses exotiques

Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities

Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-study

6. Les terrains particuliers

Personal protection against biting insects and ticks

Immunological success is predicted by enfuvirtide but not interleukin-2 therapy in immunodepressed patients

Protection personnelle antivectorielle

Pandemic Influenza A (H1N1) Infection among HIV-Infected Adults in France

Suchergebnisse filtern